Enfermedad de von Willebrand y proceso de trabajo de parto

  1. María Dolores López Medina
  2. López Araque, Ana Belén
  3. Rodríguez Castilla, Francisco
Journal:
Metas de enfermería

ISSN: 1138-7262

Year of publication: 2015

Volume: 18

Issue: 7

Type: Article

More publications in: Metas de enfermería

Abstract

It is difficult to identify and treat those haematological disorders developed during pregnancy, because there are not many tests available to guide specialists. Von Willbrand Disease is the most frequent coagulation problem, caused by a deficit in Von Willebrand Factor. We present the case of a 33-year-old pregnant woman who started her labor process pending confirmation of whether she suffered this disease, and therefore she was provided with the relevant care both during labor and in the immediate post-labor stage at the Labor & Delivery Unit. The successful management of this type of situations involves a fast identification of post-labor bleeding in order to prevent any potential complications which might alter the wellbeing of both foetus and mother.

Bibliographic References

  • Piccini CA, Lopes RS, Gomes AG, De Nardi T. Gestação e a constituição da maternidade. Psicologia em Estudo 2008; 13:63-72.
  • Townsley DM. Hematologic Complications of Pregnancy. Seminars in hematology 2013; 50(3):222-231.
  • Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8:607-21.
  • Kessler CM. Hemorrhagic disorders: coagulation factor deficiencies. In: Goldman L, Ausiello D (eds.). Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007. chap 180.
  • Wu YP, Vink T, Schiphorst M, van Zanten GH, MJ IJ, de Groot PG, et al. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol 2000; 20(6):1661-67.
  • Grover N, Boama V, Rifat CM. Pseudo (Platelet-type) von Willebrand disease in pregnancy: a case report. BMC Pregnancy and Childbirth [Internet]. 2013; 13:16. [citado 12 Mar 2015]. Disponible en: http://www.biomedcentral.com/1471-2393/13/16
  • Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood 2009; 114(6):1158-65.
  • Mannucci PM. Treatment of von Willebrand’s Disease. N Engl J Med 2004; 351(7):683-94.
  • Wee EM, Leebeek FW, Eikenboom JC. Diagnosis and management of von Willebrand disease in The Netherlands. Semin Thromb Hemost 2011; 37(5):480-487.
  • Lagarrigue J, Richez B, Julliac B, Saltel L, Nurden P, Sztark F. Analgésie péridurale obstétricale et maladie de Willebrand de type 2B. Ann P. Anesth Reanim 2013; 32(1):56-9.
  • Bolton-Maggs PH, Perry DJ, Chalmers EA et al. The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia. Centre Doctors’ Organisation. Haemophilia. 2004; 10:593-628.
  • Chandraharan E, Arulkumaran S. Surgical aspects of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008; 22:1089-102.
  • Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinalepidural anesthesia. Anesth Analog 1994; 79:1165-77.